Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

NCT: NCT05244278 · RECRUITING

NCT IDNCT05244278
StatusRECRUITING
Start Date2023-08-01
Completion2027-01-01
SponsorCentre hospitalier de l'Université de Montréal (CHUM) (OTHER)
First posted
Last updated

Brief Summary

This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions. The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operating room.

Frequently Asked Questions

What is Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies?

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies is a clinical trial registered under NCT05244278. Current status: RECRUITING.

What is the status of NCT05244278?

The current status of NCT05244278 (Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies) is: RECRUITING.

When did Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies start?

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies started on 2023-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑